FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Reg 30 of SEBI LODR, please find enclosed press release and earnings presentation for the quarter and period ended September 30, 2023. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Reg 30 of SEBI LODR, please find enclosed press release and earnings presentation for the quarter and period ended September 30, 2023. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Reg 30 of SEBI LODR, this is to inform you that the Board of Directors of the Company on November 10, 2023 has approved the appointment of Dr. Prem Kumar Nair as an Additional Director (Non-Executive & Non-Independent) of the Company with effect from November 10, 2023. Detailed disclosure in this regard is enclosed herewith. FORTIS HEALTHCARE LTD. - 532843 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Period Ended September 30, 2023.
The Board of Director of the Company in their meeting held on November 10, 2023 inter-alia considered and approved the standalone and consolidated unaudited financial results for the quarter and period ended September 30, 2023. Copies of the said financial results along with limited review reports are attached. FORTIS HEALTHCARE LTD. - 532843 - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 10, 2023
Pursuant to the provisions of reg. 30 of SEBI LODR, this is to inform you that the Board of directors at their meeting held today i.e. November 10, 2023 inter-alia, considered and approved the standalone and consolidated unaudited financial results of the Company for the quarter and period ended on September 30, 2023. Copies of the said unaudited financial results along with limited review report are enclosed. The meeting commenced at 1200 hours IST and concluded at 1815 hours IST.
Fortis Healthcare Share Price Live blog for 08 Nov 2023
Fortis Healthcare stock price went down today, 08 Nov 2023, by -0.59 %. The stock closed at 337.35 per share. The stock is currently trading at 335.35 per share. Investors should monitor Fortis Healthcare stock price closely in the coming days and weeks to see how it reacts to the news. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of upcoming conference call invite to discuss the Company''s un-audited financial results for the quarter and period ended September 30, 2023: Date & Time November 10, 2023 at 07:30 P.M. (IST) Investors / Analysts / Events: Q2FY24 Post Results Conference Call Invite. Location: Virtual Conference Please find enclosed herewith dial-in numbers alongwith participation link. No Unpublished Price Sensitive Information (UPSI) shall be shared / discussed at the investors / analysts'' meet. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI LODR Regulations, 2015, please find enclosed copies of newspaper advertisements published on November 7, 2023, inter-alia, intimating completion of the electronic transmission of postal ballot notice along with postal ballot form to the members. FORTIS HEALTHCARE LTD. - 532843 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In Compliance of Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Company has completed dispatch of postal ballot notice to its members on November 6, 2023 for seeking their approval on the following proposal: (a) To consider appointment of Mr. Ashok Pandit (DIN: 09279899) as a Non-Executive Director of the Company. Further, a copy of the Postal Ballot Notice along with Ballot Form is enclosed for kind reference. This is for your kind information and record. FORTIS HEALTHCARE LTD. - 532843 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, November 10, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2023. Further, in continuation to our letter ref. FHL/SEC/2023-24 dated September 29, 2023 captioned "Closure of Trading Window", it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 12, 2023.